In contrast, hsa-miR-194 is downregulated in EBV infection, increasing levels of IL-10, an anti-inflammatory cytokine, which promotes survival of EBV B lymphoma cells by reducing the inflammatory immune response [74]. This evidence concerns the gene IL10 and Epstein-Barr virus infection.